These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26012156)

  • 61. 15-year follow-up of a multicenter, randomized, calcineurin inhibitor withdrawal study in kidney transplantation.
    Roodnat JI; Hilbrands LB; Hené RJ; de Sévaux RG; Smak Gregoor PJ; Kal-van Gestel JA; Konijn C; van Zuilen A; van Gelder T; Hoitsma AJ; Weimar W
    Transplantation; 2014 Jul; 98(1):47-53. PubMed ID: 24521775
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A randomized trial of inhaled cyclosporine in lung-transplant recipients.
    Iacono AT; Johnson BA; Grgurich WF; Youssef JG; Corcoran TE; Seiler DA; Dauber JH; Smaldone GC; Zeevi A; Yousem SA; Fung JJ; Burckart GJ; McCurry KR; Griffith BP
    N Engl J Med; 2006 Jan; 354(2):141-50. PubMed ID: 16407509
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Conversion from calcineurin inhibitor to sirolimus for renal function deterioration in kidney allograft recipients.
    Martínez-Mier G; Méndez-López MT; Estrada-Oros J; Budar-Fernandez LF; Soto-González JI; Méndez-Machado GF; Viñas Dozal JC
    Arch Med Res; 2006 Jul; 37(5):635-8. PubMed ID: 16740435
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.
    Goldfarb DA
    J Urol; 2005 Jun; 173(6):2106-7. PubMed ID: 15879857
    [No Abstract]   [Full Text] [Related]  

  • 66. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
    Kim HC; Hwang EA; Han SY; Park SB; Kim HT; Cho WH
    Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Costimulation blockade with belatacept in renal transplantation.
    Vincenti F; Larsen C; Durrbach A; Wekerle T; Nashan B; Blancho G; Lang P; Grinyo J; Halloran PF; Solez K; Hagerty D; Levy E; Zhou W; Natarajan K; Charpentier B;
    N Engl J Med; 2005 Aug; 353(8):770-81. PubMed ID: 16120857
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Cairo kidney center protocol for rapamycin-based sequential immunosuppression in kidney transplant recipients: 2-year outcomes.
    Barsoum RS; Morsey AA; Iskander IR; Morgan MM; Fayad TM; Atalla NT; Wafik H; Grace RA; Adel N; Khalil SS
    Exp Clin Transplant; 2007 Dec; 5(2):649-57. PubMed ID: 18194116
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tacrolimus-associated mania with psychotic symptoms in a child after renal transplant.
    Gupta P; Singh J; Mahapatra A; Sharan P
    Natl Med J India; 2018; 31(5):281-282. PubMed ID: 31267993
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hepatotoxicity caused by both tacrolimus and cyclosporine after living donor liver transplantation.
    Taniai N; Akimaru K; Ishikawa Y; Kanada T; Kakinuma D; Mizuguchi Y; Mamada Y; Yoshida H; Tajiri T
    J Nippon Med Sch; 2008 Jun; 75(3):187-91. PubMed ID: 18648179
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A case of early onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
    Kim W; La BJ; Lee S; Yu HC; Cho BH; Kang MJ; Park SK
    Clin Nephrol; 2003 Feb; 59(2):148-50. PubMed ID: 12608560
    [No Abstract]   [Full Text] [Related]  

  • 73. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.3.1 Long-term immunosuppression. Late steroid or cyclosporine withdrawal.
    EBPG Expert Group on Renal Transplantation
    Nephrol Dial Transplant; 2002; 17 Suppl 4():19-20. PubMed ID: 12091624
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term follow-up of liver transplant recipients undergoing cyclosporine withdrawal.
    Te HS; Schiano TD; Conjeevaram HS; Baker AL
    Transplant Proc; 2001 Aug; 33(5):2874-7. PubMed ID: 11498194
    [No Abstract]   [Full Text] [Related]  

  • 75. Increased vascular resistance and not salt retention characterizes cyclosporine A-induced hypertension: report in an anuric patient.
    Wahba IM; Bennett WM
    Am J Transplant; 2007 Aug; 7(8):2042-6. PubMed ID: 17578503
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nonrecurrent hemolytic uremic syndrome (HUS de novo) as cause of acute renal failure after renal transplant.
    Mazzali M; Dias EP; Ribeiro-Alves MA; Homsi E; Alves-Filho G
    Ren Fail; 1997 Mar; 19(2):271-7. PubMed ID: 9101603
    [No Abstract]   [Full Text] [Related]  

  • 77. Bone disease after kidney transplantation.
    Sprague SM; Josephson MA
    Semin Nephrol; 2004 Jan; 24(1):82-90. PubMed ID: 14730514
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cholesterol reduction in cyclosporine-treated renal transplant patients: effect on platelet-derived growth factor levels and platelet activation.
    Rigatto O; Rush D; Perry Y; Walker S; Bose R; Bolli P
    Transplant Proc; 1997 Sep; 29(6):2591-2. PubMed ID: 9290755
    [No Abstract]   [Full Text] [Related]  

  • 79. CAPD--a risk factor in renal transplantation? ARF after transplantation.
    Lambert MC; Bernaert P; Vijt D; de Smet R; Lameire N
    Perit Dial Int; 1996; 16 Suppl 1():S495-8. PubMed ID: 8728255
    [No Abstract]   [Full Text] [Related]  

  • 80. Bilateral reduction mammoplasty in a patient treated with calcium channel blocker and cyclosporine after renal transplant: a case report.
    Pan Y; Grindstaff A; Cassada D; Goldman M; Taylor J
    Transplantation; 1997 Apr; 63(7):1032-3. PubMed ID: 9112362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.